Lovastatin inhibits the thrombin-induced loss of barrier integrity in bovine corneal endothelium

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 1, 2010, Pages 1-10

  Shivanna, Mahesh ^a   Jalimarada, Supriya S ^a   Srinivas, Sangly P ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DEXTRAN; GERANYLGERANYL PYROPHOSPHATE; MEVINOLIN; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN PHOSPHATASE; NOCODAZOLE; PROTEIN ZO1; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; ELECTRIC RESISTANCE; GEL ELECTROPHORESIS; MEMBRANE RESISTANCE; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; TIGHT JUNCTION; WESTERN BLOTTING;

ANIMALS; CATTLE; CELLS, CULTURED; CYTOSKELETON; ENDOTHELIUM, CORNEAL; ENZYME ACTIVATION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; RHOA GTP-BINDING PROTEIN; THROMBIN; TIGHT JUNCTIONS;

EID: 77649300314     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2009.0025     Document Type: Article

References (50)

1. Lim, J.J., and Fischbarg, J. Electrical properties of rabbit corneal endothelium as determined from impedance measurements. Biophys. J. 36:677-695, 1981.
2. Noske, W., Fromm, M., Levarlet, B. et al. Tight junctions of the human corneal endothelium: morphological and electrophysio-logical features. Ger. J. Ophthalmol. 3:253-257, 1994.
3. Srinivas, S.P., Satpathy, M., Gallagher, P. et al. Adenosine induces dephosphorylation of myosin II regulatory light chain in cultured bovine corneal endothelial cells. Exp. Eye Res. 79:543-551, 2004.
4. Edelhauser, H.F. The balance between corneal transparency and edema: the Proctor Lecture. Invest. Ophthalmol. Vis. Sci. 47:1754-1767, 2006.
5. Fischbarg, J., and Lim, J.J. Fluid and electrolyte transports across corneal endothelium. Curr. Top. Eye Res. 4:201-223, 1984.
6. Riley, M. Pump and leak in regulation of fl uid transport in rabbit cornea. Curr. Eye Res. 4:371-376, 1985.
7. Jacobson, J.R., Dudek, S.M., Birukov, K.G. et al. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am. J. Respir. Cell Mol. Biol. 30:662-670, 2004.
8. van Nieuw Amerongen, G.P., Vermeer, M.A., Nègre-Aminou, P. et al. Simvastatin improves disturbed endothelial barrier function. Circulation. 102:2803-2809, 2000.
9. Zeng, L., Xu, H., Chew, T.L., et al. HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperperme-ability by preventing RhoA activation and myosin regulatory light chain phosphorylation. FASEB J. 19:1845-1847, 2005.
10. Turner, J.R., Angle, J.M., Black, E.D., et al. PKC-dependent regulation of transepithelial resistance: roles of MLC and MLC kinase. Am. J. Physiol. 277:C554-C562, 1999.
11. Somlyo, A.P., and Somlyo, A.V. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83:1325-1358, 2003.
12. Satpathy, M., Gallagher, P., Jin, Y., et al. Extracellular ATP opposes thrombin-induced myosin light chain phosphorylation and loss of barrier integrity in corneal endothelial cells. Exp. Eye Res. 81:183-192, 2005.
13. Satpathy, M., Gallagher, P., Lizotte-Waniewski, M., et al. Thrombin-induced phosphorylation of the regulatory light chain of myosin II in cultured bovine corneal endothelial cells. Exp. Eye Res. 79:477-486, 2004.
14. Srinivas, S.P., Satpathy, M., Guo, Y., et al. Histamine-induced phosphorylation of the regulatory light chain of myosin II disrupts the barrier integrity of corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 47:4011-4018, 2006.
15. Kamm, K.E., and Stull, J.T. Dedicated myosin light chain kinases with diverse cellular functions. J. Biol. Chem. 276:4527-4530, 2001.
16. Somlyo, A.P., and Somlyo, A.V. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and nonmuscle myosin II. J. Physiol. (Lond.). 522(Pt 2):177-185, 2000.
17. van Nieuw Amerongen, G.P., Draijer, R., Vermeer, M.A., et al. Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA. Circ. Res. 83:1115-1123, 1998.
18. van Nieuw Amerongen, G.P., van Delft, S., Vermeer, M.A., et al. Activation of RhoA by thrombin in endothelial hyperperme-ability: role of Rho kinase and protein tyrosine kinases. Circ. Res. 87:335-340, 2000.
19. Mehta, D., and Malik, A.B. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86:279-367, 2006.
20. Liao, J.K., and Laufs, U. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45:89-118, 2005.
21. Stancu, C., and Sima, A. Statins: mechanism of action and effects. J. Cell. Mol. Med. 5:378-387, 2001.
22. Takemoto, M., and Liao, J.K. Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21:1712-1719, 2001.
23. Endres, M., and Laufs, U. Effects of statins on endothelium and signaling mechanisms. Stroke. 35:2708-2711, 2004.
24. Ohkawara, H., Ishibashi, T., Sakamoto, T., et al. Thrombin-induced rapid geranylgeranylation of RhoA as an essential process for RhoA activation in endothelial cells. J. Biol. Chem. 280:10182-10188, 2005.
25. Birukova, A.A., Adyshev, D., Gorshkov, B., et al. GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. Am. J. Physiol. Lung Cell Mol. Physiol. 290:L540-L548, 2006.
26. Birukova, A.A., Birukov, K.G., Adyshev, D., et al. Involvement of microtubules and Rho pathway in TGF-beta1-induced lung vascular barrier dysfunction. J. Cell. Physiol. 204:934-947, 2005.
27. Birukova, A.A., Birukov, K.G., Smurova, K., et al. Novel role of microtubules in thrombin-induced endothelial barrier dysfunction. FASEB J. 18:1879-1890, 2004.
28. Birukova, A.A., Smurova, K., Birukov, K.G., et al. Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms. J. Cell. Physiol. 201:55-70, 2004.
29. Laufs, U., Kilter, H., Konkol, C., et al. Impact of HMG CoA reductase inhibition on small GTPases in the heart. Cardiovasc. Res. 53:911-920, 2002.
30. Murthy, K.S. Signaling for contraction and relaxation in smooth muscle of the gut. Annu. Rev. Physiol. 68:345-374, 2006.
31. Sriwai, W., Zhou, H., and Murthy, K.S. G(q)-dependent signalling by the lysophosphatidic acid receptor LPA(3) in gastric smooth muscle: reciprocal regulation of MYPT1 phosphorylation by Rho kinase and cAMP-independent PKA. Biochem. J. 411:543-551, 2008.
32. Kawkitinarong, K., Linz-McGillem, L., Birukov, K.G., et al. Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am. J. Respir. Cell Mol. Biol. 31:517-527, 2004.
33. Konstantinopoulos, P.A., Karamouzis, M.V., and Papavassiliou, A.G. Post-translational modifi cations and regulation of the RAS superfamily of GTPases as anticancer targets. Nat. Rev. Drug Discov. 6:541-555, 2007.
34. Zhang, F.L., and Casey, P.J. Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65:241-269, 1996.
35. van Nieuw Amerongen, G.P., Beckers, C.M., Achekar, I.D., et al. Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler. Thromb. Vasc. Biol. 27:2332-2339, 2007.
36. van Nieuw Amerongen, G.P., Musters, R.J., Eringa, E.C., et al. Thrombin-induced endothelial barrier disruption in intact microvessels: role of RhoA/Rho kinase-myosin phosphatase axis. Am. J. Physiol., Cell Physiol. 294:C1234-C1241, 2008.
37. Eilers, U., Klumperman, J., and Hauri, H.P. Nocodazole, a micro-tubule-active drug, interferes with apical protein delivery in cultured intestinal epithelial cells (Caco-2). J. Cell Biol. 108:13-22, 1989.
38. Kolodney, M.S., and Elson, E.L. Contraction due to microtubule disruption is associated with increased phosphorylation of myosin regulatory light chain. Proc. Natl. Acad. Sci. USA. 92:10252-10256, 1995.
39. Kuhlmann, C.R., Lessmann, V., and Luhmann, H.J. Fluvastatin stabilizes the blood-brain barrier in vitro by nitric oxide-dependent dephosphorylation of myosin light chains. Neuropharmacology. 51:907-913, 2006.
40. Song, J., Deng, P.F., Stinnett, S.S., et al. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest. Ophthalmol. Vis. Sci. 46:2424-2432, 2005.
41. Jalimarada, S.S., Shivanna, M., Kini, V., et al. Microtubule disassembly breaks down the barrier integrity of corneal endothelium. Exp. Eye Res. 89:333-343, 2009.
42. Laufs, U., and Liao, J.K. Isoprenoid metabolism and the pleiotropic effects of statins. Curr. Atheroscler. Rep. 5:372-378, 2003.
43. Chen, W., Pendyala, S., Natarajan, V., et al. Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition. Am. J. Physiol. Lung Cell Mol. Physiol. 295:L575-L583, 2008.
44. Liao, J.K. Does it matter whether or not a lipid-lowering agent inhibits Rho kinase? Curr. Atheroscler. Rep. 9:384-388, 2007.
45. George, A.J., and Larkin, D.F. Corneal transplantation: the forgotten graft. Am. J. Transplant. 4:678-685, 2004.
46. Niederkorn, J.Y. Immune mechanisms of corneal allograft rejection. Curr. Eye Res. 32:1005-1016, 2007.
47. Banan, A., Farhadi, A., Fields, J.Z., et al. The delta-isoform of protein kinase C causes inducible nitric-oxide synthase and nitric oxide up-regulation: key mechanism for oxidant-induced carbonylation, nitration, and disassembly of the microtubule cytoskeleton and hyperpermeability of barrier of intestinal epithelia. J. Pharmacol. Exp. Ther. 305:482-494, 2003.
48. Banan, A., Fields, J.Z., Talmage, D.A., et al. PKC-zeta is required in EGF protection of microtubules and intestinal barrier integrity against oxidant injury. Am. J. Physiol. Gastrointest. Liver Physiol. 282:G794-G808, 2002.
49. Petrache, I., Birukova, A., Ramirez, S.I., et al. The role of the micro-tubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am. J. Respir. Cell Mol. Biol. 28:574-581, 2003.
50. Suzuki, S., Bing, H., Sugawara, T., et al. Paclitaxel prevents loss of pulmonary endothelial barrier integrity during cold preservation. Transplantation. 78:524-529, 2004.